NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 4 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Harriman, Emma; Oyefeso, Adenekan – Journal of Intellectual Disabilities, 2022
Purpose: The concept of Quality of Life (QoL) for people with neurodevelopmental disorders primarily focuses on deinstitutionalisation and community inclusion. This population, however, often presents with comorbid diagnoses and is sectioned to treatment facilities under the Mental Health Act. The aim of this paper is to review the existing…
Descriptors: Quality of Life, Intellectual Disability, Well Being, Comorbidity
Peer reviewed Peer reviewed
Direct linkDirect link
Kossyvaki, Lila; Curran, Sara – Journal of Intellectual Disabilities, 2020
Very little research has explored the impact of interventions combining music and technology on children with a dual diagnosis of autism and intellectual disabilities (ID) incorporating the active involvement of school staff. Video recordings and group interviews were used to collect data in this study. Video recordings of five children with…
Descriptors: Children, Autism, Pervasive Developmental Disorders, Comorbidity
Peer reviewed Peer reviewed
Direct linkDirect link
Cashin, Andrew; Buckley, Thomas; Trollor, Julian N.; Lennox, Nicholas – Journal of Intellectual Disabilities, 2018
Little research has been carried out on the physical health of people with autism spectrum disorder (ASD). From the studies conducted with both children and adults, few studies have moved beyond retrospective record analysis and survey and conducted health assessment. The majority of the studies are from the United States of America with a small…
Descriptors: Pervasive Developmental Disorders, Autism, Physical Health, Health Related Fitness
Peer reviewed Peer reviewed
Direct linkDirect link
Reurts, Eva Enneke; Troost, Pieter W.; Dinnissen, Mariken; Reijnen, Sam; Hoekstra, Pieter J.; Popma, Arne – Journal of Intellectual Disabilities, 2021
A retrospective chart study of patients on open-label aripiprazole treatment was conducted in the Netherlands to add to the knowledge of aripiprazole in children and young adults with mild and borderline intellectual disabilities (IDs). Fifty-three youths, mean age 14.7 ± 3.4 years and mean IQ 64.5 ±13.8, were included. Treatment responders were…
Descriptors: Mild Intellectual Disability, Drug Therapy, Outcomes of Treatment, Foreign Countries